Get started
Novartis AG ADR Cert Deposito Arg Repr 0.25 ADRsNovartis AG ADR Cert Deposito Arg Repr 0.25 ADRsNovartis AG ADR Cert Deposito Arg Repr 0.25 ADRs

Novartis AG ADR Cert Deposito Arg Repr 0.25 ADRs

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsSeasonalsBonds

NVS chart


Full chart

Key facts today


Novartis has boosted its U.S. pharmaceutical stockpiles amid potential tariffs, according to CEO Vas Narasimhan. The firm currently avoids a 39% tariff but awaits an investigation's outcome.
Analyze the impactAnalyze the impact

NVS upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪346.08 T‬ ARS
Dividend yield (indicated)
3.58%
Price to earnings Ratio (TTM)
0
Basic EPS (TTM)
9,075 ARS
Net income (FY)
‪11.94 T‬ ARS
Revenue (FY)
‪50.30 T‬ ARS
Shares float
‪1.69 B‬
Beta (1Y)
0.95

About Novartis AG


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Vasant Narasimhan
Website
novartis.com
Headquarters
Basel
Founded
1996
ISIN
ARDEUT112521
FIGI
BBG000PM0JX5
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as NVS.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NVS news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

NVS highest yielding bonds


US66989HAS7
Novartis Capital Corp. 2.75% 14-AUG-2050
Yield to maturity
5.27%
Maturity date
Aug 14, 2050
NVS5894401
Novartis Capital Corp. 4.7% 18-SEP-2054
Yield to maturity
5.26%
Maturity date
Sep 18, 2054
XPND
Novartis Capital Corp. 4.0% 20-NOV-2045
Yield to maturity
5.24%
Maturity date
Nov 20, 2045
US66989HAH1
Novartis Capital Corp. 4.4% 06-MAY-2044
Yield to maturity
5.22%
Maturity date
May 6, 2044
NVS3904288
Novartis Capital Corp. 3.7% 21-SEP-2042
Yield to maturity
5.09%
Maturity date
Sep 21, 2042
XPNC
Novartis Capital Corp. 3.0% 20-NOV-2025
Yield to maturity
4.50%
Maturity date
Nov 20, 2025
NVS5894400
Novartis Capital Corp. 4.2% 18-SEP-2034
Yield to maturity
4.45%
Maturity date
Sep 18, 2034
NVS5894399
Novartis Capital Corp. 4.0% 18-SEP-2031
Yield to maturity
4.02%
Maturity date
Sep 18, 2031
US66989HAR9
Novartis Capital Corp. 2.2% 14-AUG-2030
Yield to maturity
3.98%
Maturity date
Aug 14, 2030
US66989HAN8
Novartis Capital Corp. 3.1% 17-MAY-2027
Yield to maturity
3.81%
Maturity date
May 17, 2027
NVS5894398
Novartis Capital Corp. 3.8% 18-SEP-2029
Yield to maturity
3.81%
Maturity date
Sep 18, 2029

See all NVS bonds 

Sparks


Curated watchlists where NVS is featured.

See all sparks